ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,819.10
0.78%
S&P ASX All Technology
3,330.90
0.60%
Brent Oil
67.075
0.00%
US Dollar vs AUD
1.56535
0.00%
Bitcoin
85,172.82
0.82%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Boussard & Gavaudan Holding Limited (BGHS) Share Price

Boussard & Gavaudan Holding Limited

Boussard & Gavaudan Holding Limited (BGHS)

Boussard and Gavaudan Holding
2,420.00
0.00
(0.00%)
Closed 19 April 1:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2,420.00
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
2,150.00 52 Week Range 2,420.00
Market Cap
300.627M
Previous Close
2,420.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
12,422,606
Dividend Yield
-
PE Ratio
-112.14
Earnings Per Share (EPS)
-0.22
Revenue
3.79M
Net Profit
-2.68M

About Boussard & Gavaudan Holding Limited

Sector
Trust,ex Ed,religious,charty
Industry
Trust,ex Ed,religious,charty
Website
www.bgholdingltd.com
Headquarters
London, Gbr
Founded
-
Boussard & Gavaudan Holding Limited is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker BGHS. The last closing price for Boussard & Gavaudan was 2,420p. Over the last year, Boussard & Gavaudan shares have traded in a share price range of 2,150.00p to 2,420.00p.

Boussard & Gavaudan currently has 12,422,606 shares in issue. The market capitalisation of Boussard & Gavaudan is £300.63 million. Boussard & Gavaudan has a price to earnings ratio (PE ratio) of -112.14.

Ask ADVFN Intelligence (AI)

BGHS Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10024202420242000DE
40024202420242000DE
120024202420242000DE
26401.6806722689123802420220012400DE
5227012.558139534921502420215052324.47284345DE
15642021200024201850192011.09051906DE
260115591.3043478261126524201250361753.20233582DE

BGHS - Frequently Asked Questions (FAQ)

What is the current Boussard & Gavaudan share price?
The current share price of Boussard & Gavaudan is 2,420.00p
How many Boussard & Gavaudan shares are in issue?
Boussard & Gavaudan has 12,422,606 shares in issue
What is the market cap of Boussard & Gavaudan?
The market capitalisation of Boussard & Gavaudan is GBP 300.63M
What is the 1 year trading range for Boussard & Gavaudan share price?
Boussard & Gavaudan has traded in the range of 2,150.00p to 2,420.00p during the past year
What is the PE ratio of Boussard & Gavaudan?
The price to earnings ratio of Boussard & Gavaudan is -112.14
What is the cash to sales ratio of Boussard & Gavaudan?
The cash to sales ratio of Boussard & Gavaudan is 79.29
What is the reporting currency for Boussard & Gavaudan?
Boussard & Gavaudan reports financial results in EUR
What is the latest annual turnover for Boussard & Gavaudan?
The latest annual turnover of Boussard & Gavaudan is EUR 3.79M
What is the latest annual profit for Boussard & Gavaudan?
The latest annual profit of Boussard & Gavaudan is EUR -2.68M
What is the registered address of Boussard & Gavaudan?
The registered address for Boussard & Gavaudan is ONE VINE STREET, LONDON, W1J 0AH
What is the Boussard & Gavaudan website address?
The website address for Boussard & Gavaudan is www.bgholdingltd.com
Which industry sector does Boussard & Gavaudan operate in?
Boussard & Gavaudan operates in the TRUST,EX ED,RELIGIOUS,CHARTY sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LLAILunglife Ai Inc
3.00p
(233.33%)
9.57M
CTAICatenai Plc
0.285p
(83.87%)
450.76M
ALBAAlba Mineral Resources
0.0315p
(65.79%)
685.89M
CLCOCloudcoco Group Plc
0.125p
(47.06%)
7.13M
MODER8 Capital Investments Plc
1.60p
(45.45%)
23.61M
TERNTern Plc
1.125p
(-22.41%)
3.54M
IOMIomart Group Plc
27.00p
(-14.56%)
1.14M
STXShield Therapeutics Plc
2.30p
(-13.21%)
9.37M
NTQEnteq Technologies Plc
1.50p
(-11.76%)
1.21M
VRCIVerici Dx Plc
1.875p
(-11.76%)
418.93k
CHPCaledonian Holdings Plc
0.0025p
(0.00%)
3.96B
ALBAAlba Mineral Resources
0.0315p
(65.79%)
685.89M
CTAICatenai Plc
0.285p
(83.87%)
450.76M
CPAICapai Plc
0.455p
(2.25%)
394.69M
ORCPOracle Power Plc
0.0235p
(-2.08%)
292.2M

Discussion

View Full Feed
ohsaycanyousee82 ohsaycanyousee82 1 minute ago
Wow!!!

That sure is a lot of “entertaining” time and effort to neutralize George. I’ve had George on ignore for a long, long time. I’m very surprised that you don’t, as well as Biochecker.

But I always forget to factor in the entertainment value.

Were
AVXL
tech0200 tech0200 2 minutes ago
Even if the plants are earthquake proof the disruption of a major earthquake would cause a lot of problems. Will the employees be able to go to work as usual? Not likely. Will deliveries and shipments proceed as usual? Not likely. Would the clients be happy without getting their products on tim
CDMO
Hoskuld Hoskuld 3 minutes ago
bcblbrbm, September-November this year is the likely range for top-line release. Originally, the end date was 15-MAY-2025. They have expanded the trial by some undisclosed number of patients so I think it is safe to estimate end of June at minimum. The company has not updated the clinical trial r
AVXL
WOOFERHEAD WOOFERHEAD 3 minutes ago
"Disruptive Hydrogen Technologies (DHT) Energy Corp is a sister company to WPP Energy and HyFi Corp".

https://dhtenergy.com/wp-content/uploads/2024/05/65_Green_H2_Arica_Chile.pdf

GLTA

$BOPO BOPO $BOPO
BOPO
sharkey1 sharkey1 4 minutes ago
Yes Nasdaq, and I'm hoping it was all shipped before March 31st along with A huge order for Lisdex.

Can sleep till June ,

lol
ELTP
ubueltp ubueltp 6 minutes ago
If I were guessing, your an engineer or an accountant, am I correct?
MPW
gdog gdog 7 minutes ago
I have seen the nothern lights many times over the yrs here in MI. many = 5-6
monocle monocle 11 minutes ago
The shares outstanding are already 3x higher than when the first fs came out and they still need 100s of millions raised with equity. Jim has stressed that REEs are a byproduct only.

The ceiling is much lower now imo.
NB
NASDAQ2020 NASDAQ2020 16 minutes ago
Elite sold out their usual quota of active ingredient (api) of Adderall due to high demand .
Kirkov working OT !

It’s about to get real !!!
ELTP
Hoskuld Hoskuld 18 minutes ago
Gerry, there is no evidence that any of the AChEIs or BChEIs are more than just a little effective or work for more that 6 months. If a patient is in the trial then that patient is already far past 6 months before starting, almost certainly. I think you can be VERY confident that all the benefit i
AVXL
Ooou812 Ooou812 18 minutes ago
Thanks for that most important friendly reminder. 
NLST
BIOCHEMUP BIOCHEMUP 19 minutes ago
This Will short squeeze.
AREC
cottonisking cottonisking 21 minutes ago
LBHI's Cts' parity rights are good.

Preferred Equity Distributions
Following progress made during the Reporting Period, the Directors proposed, in consultation with the Administrators,
that the Company make a further significant distribution by way of dividend to LBHI2,
LEHNQ
Hoskuld Hoskuld 22 minutes ago
Gerry and Investor, the trial was run exactly as every other AD trial was run: both placebo and drug groups receive current SOC (an ineffective menagerie of drugs.) SOC is basically...nothing.
AVXL
bcblbrbm bcblbrbm 22 minutes ago
Could someone please post the date (range) for release of 3-71 Phase 2B, expansion data for Schizophrenia?
AVXL
TheSprinx TheSprinx 24 minutes ago
Read this thread:https://x.com/karenkinghaven/status/1913419852070654381?s=46&t=FWyCU7KfIDokGToTtqinIg
HMBL
Hoskuld Hoskuld 25 minutes ago
Correct. Also hoping all of us benefit in a big way.
AVXL
golfbag golfbag 27 minutes ago
I believe we have all of our permits, correct?

Trump to fast-track permits for 10 mining projects, including Rio Tinto's Arizona copper mine
RIO +1.77%Apr. 18, 2025 9:43 PM ET19 Comments
The Trump administration said on Friday it will fast-track permitting for 10 mining
PPTA SLI
pepeoil pepeoil 32 minutes ago
It is amazing how cohens pr guy know all of the intimate details of cohens trainwrecks that began several years ago, yet he has only been the pr guy a few months. Lol. Very similar personalities, both very rude with parallel narcissistic traits. Wink wink
AZRH
GrandAdmiralThrawn GrandAdmiralThrawn 33 minutes ago
Absolute, agree!
TWOH
NASDAQ2020 NASDAQ2020 33 minutes ago
The active ingredient is. The singular (one) Active Pharmaceutical Ingredient in Adderall is Dextroamphetamine

An active pharmaceutical ingredient (API) is the component of an over-the-counter (OTC) or prescription medication that produces its intended health effects. If a prescriptio
ELTP
rachelgreen1 rachelgreen1 35 minutes ago
Checking out online travel platforms—any feedback on Flightd. pro’s growth and market presence?

Your Recent History

LSE
BGHS
Boussard & Gavaudan
AQSE
GLR.GB
Galileo Resources
NASDAQ
AGNC
AGNC Investment
CSE
QBC
Quebec Pegmatite
NASDAQ
HNVR
Hanover Bancorp
NASDAQ
MDLZ
Mondelez
NASDAQ
ASCAU
A SPAC I Acquisition
NASDAQ
CBXYX
Ci Canadian Equity Corpo...
NASDAQ
SILC
Silicom
NASDAQ
CBUKX
Ci Canadian Dividend Cor...
TG
CVCA
Carnival
NASDAQ
CANQX
Canoe Preferred Share Po...
NASDAQ
FDZIX
Bmo Precious Metals Fund...
NASDAQ
CDPYX
Ci Global Equity & Incom...
NASDAQ
FCVJX
Bmo Balanced Etf Portfol...
NASDAQ
CFFDX
Ci Mosaic Esg Balanced E...
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads